insights_auto
Why is EDIT down 3,39%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,71 $
arrow_downward
-3,39%(-0,060) 1D
1,72 $
arrow_upward
+0,58% (+0,0100)bedtimeAfter hours
Closed: 19 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,80 $
High
1,83 $
Low
1,70 $
Mkt. cap
263,92 մլն
Avg. vol.
2,38 մլն
Volume
1,93 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,80 $
High
1,83 $
Low
1,70 $
Mkt. cap
263,92 մլն
Avg. vol.
2,38 մլն
Volume
1,93 մլն
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
ChartMill
·
1 ժամ առաջ
S&P 500 Top Movers: Gainers and Losers Today
FXStreet
·
16 րոպե առաջ
Dow Jones Industrial Average falls over 1,000 points as Anthropic IPO dominates
Investing.com
·
8 րոպե առաջ
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 2.19%
Traders Union
·
1 ժամ առաջ
Caleb Franzen: S&P 500 performance and AI stocks diverged under Powell and Warsh
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc